Status:

COMPLETED

Efficacy of DBM Fasciatherapy for Patients Suffering From Chronic Low Back Pain

Lead Sponsor:

FasciaFrance

Collaborating Sponsors:

University Fernando Pessoa

Conditions:

Low Back Pain

Eligibility:

All Genders

30-60 years

Phase:

NA

Brief Summary

Low back pain (LBP) is pain localized below the costal margin and above the inferior gluteal folds. It may be associated with radiculalgia. Non-specific LBP refers to LBP without specific problems suc...

Eligibility Criteria

Inclusion

  • First consultation for Low Back Pain with the practitioner
  • Having a diagnostic of chronic non-specific Low Back Pain based on the French Haute Autorité de Santé guidelines (https://www.has-sante.fr/upload/docs/application/pdf/2019-04/fm\_lombalgie\_v2\_2.pdf):
  • excluding specific Low Back Pain (tumor, infection, inflammation, etc.)
  • no red flag
  • Low Back Pain for more than 3 months
  • Having had the French validated version of:
  • evaluation of pain intensity with Visual Analog Scale
  • STarT Back Screening Tool questionnaire
  • Dallas Pain questionnaire

Exclusion

  • Specific Low Back Pain (rheumatologist disease, tumoral compression, central neurological pathology, etc.)
  • Psychiatric disorder (apart from the usual co-morbidities of chronic low back pain)
  • Pregnancy or breastfeeding
  • Being under guardianship or curatorship
  • Deprivation of liberty or legal protection measure
  • Being unable to give consent
  • Being unable of fill out a questionnaire

Key Trial Info

Start Date :

May 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 6 2023

Estimated Enrollment :

188 Patients enrolled

Trial Details

Trial ID

NCT04812678

Start Date

May 1 2021

End Date

September 6 2023

Last Update

April 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

FasciaFrance

Clermont-Ferrand, France, 63000